Ignite Creation Date:
2024-05-06 @ 5:56 PM
Last Modification Date:
2024-10-26 @ 2:38 PM
Study NCT ID:
NCT05487391
Status:
RECRUITING
Last Update Posted:
2022-08-04
First Post:
2022-08-01
Brief Title:
A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection
Sponsor:
Qilu Pharmaceutical Co Ltd
Organization:
Qilu Pharmaceutical Co Ltd
Organization Data
Organization:
Qilu Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
QL1706-304
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Qilu Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None